EP2535716 - Bibliographic data
Marqueur de cancer et cible thérapeutique
| Last update | 29/05/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Européen |
| (73) Holder |
CANCER RESEARCH TECHNOLOGY LIMITED Angel Building
407 St John Street
London
EC1V 4AD
Royaume-Uni
|
|---|---|
| (72) Inventors |
Violet Slettenaar c/o Institute of Cancer
Queen Mary University of London
Charterhouse Square
London EC1M 6BQ
Royaume-Uni
Julia Wilson c/o Institute of Cancer
Queen Mary University of London
Charterhouse Square
London EC1M 6BQ
Royaume-Uni
Yaohe Wang c/o Institute of Cancer
Queen Mary University of London
Charterhouse Square
London EC1M 6BQ
Royaume-Uni
Tiziana Schioppa c/o Institute of Cancer
Queen Mary University of London
Charterhouse Square
London EC1M 6BQ
Royaume-Uni
Frances Balkwill c/o Institute of Cancer
Queen Mary University of London
Charterhouse Square
London EC1M 6BQ
Royaume-Uni
|
| (74) Agent |
Mail recipient RIGBY, BARBARA NICOLE Dehns
St Bride's House
10 Salisbury Square
London EC4Y 8JD
Royaume-Uni
|
| (21) Request number | EP12183760.3 |
|---|---|
| (22) Request date | 18/09/2008 |
| (11) Publication number | EP2535716 |
|---|---|
| Publication date | 02/11/2016 |
| (54) Title of the invention | Marqueur de cancer et cible thérapeutique |
|---|---|
| (51) International classification | G01N 33/574, A61K 31/00, G01N 33/50 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 0718167 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 10 -
Amount: 165 € -
Due date 02/10/2017
Surtax: 10 - Amount: 33 € - Due date 03/04/2018 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 02/11/2016 Entrée en période de grâce du brevet d'invention - Legal date 03/10/2017 Déchéance du brevet d'invention après période de grâce - Legal date 02/10/2017 |